Samsung Bioepis has failed to invalidate a second medical use patent for Janssen's blockbuster Stelara in the Netherlands. The District Court The Hague dismissed the revocation action, but the Korean
the pharmaceutical sector. The amended law, passed by the National People's Congress Standing Committee on Saturday, aims to provide a long-term mechanism for combating patent infringement, promoting
The German pharmaceutical company Boehringer Ingelheim sought to pre-emptively prohibit Zentiva from selling generic versions of its respiratory drug Ofev. However, UPC judges saw no grounds for
infringes a patent held by Fresenius Kabi, thus overturning a first-instance decision. Fresenius Kabi alleges that Biogen’s Imraldi has infringed its EP 3 145 488 B1 for a ‘liquid pharmaceutical
total 1 pages, 4 items